Boston Scientific Settles Guidant Heart Devices Allegations for $30 Million
Boston Scientific Inc., already embroiled in transvaginal mesh litigation, agreed to pay $30 million stemming from claims that they knowingly sold defective heart devices that were implanted in Medicare patients. Boston Scientific acquired Guidant in 2006 and bought the company for $27 billion.
From 2002 to 2005, Guidant knowingly sold the defibrillator devices even though it knew they could short-circuit and become ineffective at correcting heartbeat rhythms.
In August 2013, Judge Joseph Goodwin announced the bellwether case schedule for the Boston Scientific vaginal mesh cases occurring in West Virginia. The first set of Boston Scientific trials is set to begin 2/11/2014 and the second set commencing on 6/17/2014.
The Brandi Law Firm is nationally recognized for its long involvement in cases involving defects in drugs or devices, from DePuy metal on metal hips, Fosamax, Actos to vaginal mesh. Currently, the firm is actively investigating potential claims for women who have taken Lipitor and been diagnosed with Type II Diabetes, which medical studies indicate, may be causally related. If you would like more information, please contact the Brandi Law Firm by e-mail or call 415-989-1800 or (800) 481-1615.